|
Bernhard Moser and Pius Loetscher answers a
few questions about this month's fast breaking paper in the field of
Immunology.
From
•>>October 2005
Field:
Immunology
Article Title: Chemokines: multiple levels of leukocyte migration control
Authors: Moser,
B;Wolf, M;Walz, A;Loetscher,
P
Journal: TRENDS IMMUNOL
Volume: 25
Page: 75-84
Year: FEB 2004
* Univ Bern, Theodor Kocher Inst, Freiestr 1, CH-3012 Bern, Switzerland.
* Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland.
* Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.
|
Why
do you think your paper is highly cited?
|
“This review article gives a timely update of the development and progress in chemokine research and is focused on the highly competitive area of lymphocyte traffic control.”
|
|
This review article gives a timely update of the development
and progress in chemokine research and is focused on the highly
competitive area of lymphocyte traffic control. It emphasizes
the paradigm that predicts an intimate relationship between
leukocyte migration properties and leukocyte function. In other
words, knowledge about the migration and localization properties
of a given type of leukocytes allows us to predict its state of
differentiation and function in immune processes. These
migration properties are defined by adhesion molecules and
chemokines, which form the largest class of cytokines.
Chemokines act as chemoattractants by binding to chemokine
receptors present on leukocytes. The information in this article
is useful to chemokine specialists and those who wish to enter
this highly competitive field of research.
Could
you summarize the significance of your paper in layman's terms?
This review article is focused on one aspect in chemokine
research, namely the contribution of chemokines to the control
of lymphocyte traffic. In essence, chemokines guide lymphocyte
placement and relocation in all aspects of adaptive immunity,
including lymphopoiesis, initiation of effector lymphocyte
generation in lymph nodes and lymphocyte recruitment to sites of
inflammation as well as immune surveillance of peripheral
tissues. Traffic of effector/memory T cells is discussed in
great detail.
How
did you become involved in this research?
We have a long-standing interest in this area of research,
dating back to the earliest chemokines that were discovered in
the late 1980s. One of our main contributions was the discovery
that not only cells of the innate immune system, such as
neutrophils and monocytes, but also T lymphocytes of the
adaptive immune system are targeted by chemokines. Current
research activities are centered on the mechanisms controlling
the steady-state traffic of long-lived memory T lymphocytes
through secondary lymphoid and non-lymphoid tissues.
Bernhard Moser, P.D., Ph.D.
Institute of Cell Biology
University of Bern
Bern, Switzerland
Pius Loetscher, P.D., Ph.D.
Novartis Institutes for BioMedical Research
Rheumatoid Arthritis
Basel, Switzerland
Read
New
Hot Paper comments from the above authors for another paper in the
field of Immunology.
|
ESI Special Topics,
October 2005
Citing URL - http://www.esi-topics.com/fbp/2005/october05-Moser_Loetscher.html
|
|